Loading ...

Peanut Oral Immunotherapy in Children

(

IMPACT

)

ITN Protocol #:

ITN050AD

Branded Name:

IMPACT

ClinicalTrials.Gov ID:

NCT01867671

Treatment Protocol #:

Therapeutic Area:

Allergy & Asthma

Current Status:

Complete

Summary:

Oral Immunotherapy for Induction of Tolerance and Desensitization in Peanut-Allergic Children

Clinical Operations Associate Director

Clinical Operations Manager

ITN Biologist

ITN Biostat

ITN Clinical Trial Physician

NIAID Project Manager

Rho Scientist

PPD Lead Monitor

Study Personnel:

Protocol Chair

Wesley Burks, MDwesley.burks@unc.edu

Work: 

919-966-1505

Protocol Chair

Don Whitehousedwhitehouse@immunetolerance.org

Work: 

415-353-4426

Protocol Chair

Don Whitehousedwhitehouse@immunetolerance.org

Work: 

415-353-4426

Protocol Chair

David Larsondlarson@immunetolerance.org

Work: 

(240) 235-6159

Protocol Chair

Tielin Qin

Work: 

(240) 235-6139

Protocol Chair

Srinath Sanda, MDssanda@immunetolerance.org

Work: 

415-353-4414

Protocol Chair

Joy LaurienzoJLaurienzo@niaid.nih.gov

Work: 

301-451-4415

Protocol Chair

Jennifer Stasiakjennifer_stasiak@rhoworld.com

Work: 

919-595-6329